4
Changes in Ownership
Propanc Biopharma, Inc. Filed Acc 0001493152-21-020758
CEO/CFO acquired 8,728,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nathanielsz James Andrew CEO/CFO | 2021-08-17 | Grant or award | +5,928,000 | 5,928,004 | I | ||
| Nathanielsz James Andrew CEO/CFO | 2021-08-17 | Grant or award | +2,800,000 | 2,800,000 | I |
Loading xslF345X03/ownership.xml…